|
|
 Previous Article | Table of Contents | Next Article 
Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia
Norbert Gattermann,
Stefan Retzlaff,
Yan-Ling Wang,
Götz Hofhaus,
Jürgen Heinisch,
Carlo Aul, and
Wolfgang Schneider
From the Department of Hematology, Oncology, and Clinical Immunology, Institute of Biochemistry, and the Institute of Microbiology, Heinrich-Heine-University, Düsseldorf, Germany.
Mitochondrial iron overload in acquired idiopathic sideroblastic anemia (AISA) may be attributable to mutations of mitochondrial DNA (mtDNA), because these can cause respiratory chain dysfunction, thereby impairing reduction of ferric iron (Fe3+) to ferrous iron (Fe2+). The reduced form of iron is essential to the last step of mitochondrial heme biosynthesis. It is not yet understood to which part of the respiratory chain the reduction of ferric iron is linked. In two patients with AISA we identified point mutations of mtDNA affecting the same transmembrane helix within subunit I of cytochrome c oxidase (COX I; ie, complex IV of the respiratory chain). The mutations were detected by restriction fragment length polymorphism analysis and temperature gradient gel electrophoresis. One of the mutations involves a T  C transition in nucleotide position 6742, causing an amino acid change from methionine to threonine. The other mutation is a T C transition at nt 6721, changing isoleucine to threonine. Both amino acids are highly conserved in a wide range of species. Both mutations are heteroplasmic, ie, they establish a mixture of normal and mutated mitochondrial genomes, which is typical of disorders of mtDNA. The mutations were present in bone marrow and whole blood samples, in isolated platelets, and in granulocytes, but appeared to be absent from T and B lymphocytes purified by immunomagnetic bead separation. They were not detected in buccal mucosa cells obtained by mouthwashes and in cultured skin fibroblasts examined in one of the patients. In both patients, this pattern of involvement suggests that the mtDNA mutation occurred in a self-renewing bone marrow stem cell with myeloid determination. Identification of two point mutations with very similar location suggests that cytochrome c oxidase plays an important role in the pathogenesis of AISA. COX may be the physiologic site of iron reduction and transport through the inner mitochondrial membrane.
Blood, Vol. 90 No. 12 (December 15), 1997:
pp. 4961-4972
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. A. Petros, A. K. Baumann, E. Ruiz-Pesini, M. B. Amin, C. Q. Sun, J. Hall, S. Lim, M. M. Issa, W. D. Flanders, S. H. Hosseini, et al.
mtDNA mutations increase tumorigenicity in prostate cancer
PNAS,
January 18, 2005;
102(3):
719 - 724.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Friedman, M. F. Lopez, M. D. Fleming, A. Rivera, F. M. Martin, M. L. Welsh, A. Boyd, S. R. Doctrow, and S. J. Burakoff
SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness
Blood,
October 15, 2004;
104(8):
2565 - 2573.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Linnartz, R. Anglmayer, and S. Zanssen
Comprehensive Scanning of Somatic Mitochondrial DNA Alterations in Acute Leukemia Developing from Myelodysplastic Syndromes
Cancer Res.,
March 15, 2004;
64(6):
1966 - 1971.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Gattermann, M. Wulfert, B. Junge, U. Germing, R. Haas, and G. Hofhaus
Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome
Blood,
February 15, 2004;
103(4):
1499 - 1502.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K J Livesey, V L C Wimhurst, K Carter, M Worwood, E Cadet, J Rochette, A G Roberts, J J Pointon, A T Merryweather-Clarke, M L Bassett, et al.
The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading
J. Med. Genet.,
January 1, 2004;
41(1):
6 - 10.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Rotig and A. Munnich
Genetic Features of Mitochondrial Respiratory Chain Disorders
J. Am. Soc. Nephrol.,
December 1, 2003;
14(12):
2995 - 3007.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Antonicka, S. C. Leary, G.-H. Guercin, J. N. Agar, R. Horvath, N. G. Kennaway, C. O. Harding, M. Jaksch, and E. A. Shoubridge
Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with isolated COX deficiency
Hum. Mol. Genet.,
October 16, 2003;
12(20):
2693 - 2702.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. G. Shin, S. Kajigaya, B. C. Levin, and N. S. Young
Mitochondrial DNA mutations in patients with myelodysplastic syndromes
Blood,
April 15, 2003;
101(8):
3118 - 3125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Uusimaa, S. Finnila, L. Vainionpaa, M. Karppa, R. Herva, H. Rantala, I. E. Hassinen, and K. Majamaa
A Mutation in Mitochondrial DNA-Encoded Cytochrome c Oxidase II Gene in a Child With Alpers-Huttenlocher-Like Disease
Pediatrics,
March 1, 2003;
111(3):
e262 - 268.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Tehranchi, B. Fadeel, A.-M. Forsblom, B. Christensson, J. Samuelsson, B. Zhivotovsky, and E. Hellstrom-Lindberg
Granulocyte colony-stimulating factor inhibits spontaneous cytochrome c release and mitochondria-dependent apoptosis of myelodysplastic syndrome hematopoietic progenitors
Blood,
February 1, 2003;
101(3):
1080 - 1086.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. T. Gregg, V. Reddy, and J. T. Prchal
Copper deficiency masquerading as myelodysplastic syndrome
Blood,
July 30, 2002;
100(4):
1493 - 1495.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. L. Greenberg, N. S. Young, and N. Gattermann
Myelodysplastic Syndromes
Hematology,
January 1, 2002;
2002(1):
136 - 161.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. S. Friedman, V. I. Rebel, R. Derby, K. Bell, T.-T. Huang, F. A. Kuypers, C. J. Epstein, and S. J. Burakoff
Absence of Mitochondrial Superoxide Dismutase Results in a Murine Hemolytic Anemia Responsive to Therapy with a Catalytic Antioxidant
J. Exp. Med.,
April 16, 2001;
193(8):
925 - 934.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. L. Karadimas, P. Greenstein, C. M. Sue, J. T. Joseph, K. Tanji, R. G. Haller, T. Taivassalo, M. M. Davidson, S. Shanske, E. Bonilla, et al.
Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA
Neurology,
September 12, 2000;
55(5):
644 - 649.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Hellstrom-Lindberg, C. Willman, A. J. Barrett, and Y. Saunthararajah
Achievements in Understanding and Treatment of Myelodysplastic Syndromes
Hematology,
January 1, 2000;
2000(1):
110 - 132.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Rossignol, M. Malgat, J.-P. Mazat, and T. Letellier
Threshold Effect and Tissue Specificity. IMPLICATION FOR MITOCHONDRIAL CYTOPATHIES
J. Biol. Chem.,
November 19, 1999;
274(47):
33426 - 33432.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. DiMauro, E. Bonilla, and D. C. De Vivo
Does the Patient Have a Mitochondrial Encephalomyopathy?
J Child Neurol,
November 1, 1999;
14(1_suppl):
S23 - S35.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. C. Radisky, M. C. Babcock, and J. Kaplan
The Yeast Frataxin Homologue Mediates Mitochondrial Iron Efflux. EVIDENCE FOR A MITOCHONDRIAL IRON CYCLE
J. Biol. Chem.,
February 19, 1999;
274(8):
4497 - 4499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
